Studying Melatonin and Recovery in Teens
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 45 people, planned
- Started
- 30 May 2024
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Fast-Dissolve Melatonin Pill
- Fast-Dissolve Placebo Pill
- Record updated
- 27 October 2026
Who can take part
- Age
- 12 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- Patients/youth:
- Age 12-18 years
- Participants undergoing elective major musculoskeletal surgery for eligible conditions
- California state resident
- Regular access to internet and smartphone
- Can read and understand English or Spanish; Parents/caregivers
- Biological parent or legal guardian of youth
- Can read and understand English or Spanish
Who cannot take part
- Prescription medication for premorbid insomnia
- Does not agree to a 1-week washout if taking over the counter supplements or other sleep aids prior to the start of the study medication
- Psychiatric admission in prior 30 days
- Patients that underwent major surgery in the last 3 months, or those that have not fully recovered from a prior surgery
- Cognitive impairment or developmental delay
- High risk for sleep related breathing disorder
- Chronic medical condition that is severe/systemic or requires regular treatment regimen
- Any serious underlying medical or psychiatric condition, that, in the opinion of the investigator, would contraindicate the patient's participation in the study
- Patients/youth
- BMI ≥ 99th percentile
- Enrollment in another therapeutic study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in United States.
- Lucile Packard Children's HospitalPalo Alto, United StatesContact: Jennifer A Rabbitts, M.D.Taking people
About the trial
What the trial wants to find out
The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that may be effective in promoting longer, higher quality sleep. This study will assess the feasibility and acceptability of melatonin for teens undergoing major musculoskeletal surgery, as well as determine optimal measured outcomes (sleep, pain, health-related quality of life) at short- and long-term follow-up.
The 2 groups in the trial
- 3mg fast-dissolve pillPlacebo, for comparison
Participants will take a placebo of 3mg fast-dissolve pill (without melatonin), complete surveys, and wear an actigraphy device during the specified study period.
Treatment: Fast-Dissolve Placebo Pill
- 3mg fast-dissolve pill (containing melatonin)Treatment being tested
Participants will take 3mg in fast-dissolve pill form containing the active ingredient melatonin, complete surveys, and wear an actigraphy device during the specified study period.
Treatment: Fast-Dissolve Melatonin Pill
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SurgerySMART: Studying Melatonin and Recovery in Teens
- Criteria questions
- Built from NCT06093477, who can take part
- Record updated
- 27 October 2026